[Form 4] Performant Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Simeon M. Kohl, Chief Executive Officer and a director of Performant Healthcare, Inc. (PHLT), reported equity activity on 08/14/2025. The filing shows 20,250 restricted stock units (RSUs) were treated as acquired under a Rule 10b5-1 plan and that the Reporting Person now beneficially owns 571,311 shares of common stock after the transaction. Separately, 7,908 shares were surrendered to cover tax withholding on RSU vesting at an indicated price of $7.61 per share, leaving 563,403 shares beneficially owned in one line of the disclosure.

The RSUs were originally granted on August 13, 2021, vesting in four equal installments tied to service through each anniversary and subject to acceleration under the Reporting Person's change-in-control agreement. The filing is signed by an attorney-in-fact on behalf of Mr. Kohl.

Insights

Corporate Governance Expert

TL;DR: CEO received and vested RSUs, surrendered some shares for taxes; standard executive compensation mechanics with limited immediate market impact.

The transaction consists of RSU vesting and the tax-related surrender of shares, both routine for executive equity compensation. The use of a 10b5-1 plan for the acquisition entry suggests pre-planned execution timing. The size—20,250 RSUs awarded/vested against reported beneficial ownership—does not indicate a material change to control or ownership concentration. Investors should view this as compensation realization rather than active open-market selling for diversification.

Securities Analyst

TL;DR: Vesting and tax-withholding occurred; transactions are administrative and unlikely to materially affect PHLT's capitalization.

The filing discloses vesting mechanics and a surrender of 7,908 shares to satisfy tax liabilities at a reported price of $7.61. The net beneficial ownership figures reported (571,311 and 563,403 shares on different lines) should be read carefully; they reflect outstanding beneficial holdings after respective line-item transactions. From a market-impact perspective, these are routine insider compensation events rather than strategic purchases or disposals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kohl Simeon

(Last) (First) (Middle)

900 SOUTH PINE ISLAND ROAD

SUITE 150

(Street)

PLANTATION FL 33324

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Performant Healthcare Inc [ PHLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	08/14/2025		M		20,250	A	$0	571,311	D
Common Stock, par value $0.0001 per share	08/14/2025		F		7,908(1)	D	$7.61	563,403	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(2)	08/14/2025		M			20,250	(3)	(3)	Common Stock	20,250	$0(2)	0	D

Explanation of Responses:

1. Shares surrendered to pay tax liability due on vesting of Restricted Stock Units

2. Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to the Reporting Person.

3. Restricted Stock Unit award was granted on August 13, 2021 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.

Remarks:

	/s/ Rohit Ramchandani, Attorney-in-Fact for Simeon M. Kohl	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.